Skip to content

Evaluation of pregnancy outcomes in IVF cycles with uterine support with progesterone, Prolotex, and Cyclogest in the infertility center.

Evaluation of pregnancy results in IVF cycles with luteal phase support with progesterone, prolotex, and Cyclogest in infertility center.

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
IRCT
Registry ID
IRCT20141217020351N12
Enrollment
309
Registered
2020-12-06
Start date
2019-08-06
Completion date
Unknown
Last updated
2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Types of female infertility. Female infertility, unspecified

Interventions

Intervention 1: Intervention group:In the first group
To transfer the frozen fetus on the second day of menstruation, 2 mg of Estradiol Valerate tablets are given three times a day for 9 days, and if there is an endometrium with a thickness of more than
To transfer the frozen fetus on the second day of menstruation, 2 mg Estradiol Valerate tablets are given three times a day for 9 days, and if there is an endometrium with a thickness of more than 7 m
To transfer the frozen fetus on the second day of menstruation, 2 mg Estradiol Valerate tablets are given three times a day for 9 days. If there is an endometrium with a thickness of more than 7 mm, P

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 42 Years

Inclusion criteria

Inclusion criteria: Infertile women aged 18 to 42 years BMI less than 30 Having less than three IVF cycles FSH < 15 U/L Estradiol less than 80 pg / ml Having a normal uterine cavity on a recent hysteroscopy, sonohistogram, or hysterosalpingogram

Exclusion criteria

Exclusion criteria: Intramural fibroids deforming the uterine cavity Endometriosis stage three and four Hydrosalpinx History of poor response to treatment Spontaneous abortion Adrenal disease Thyroid disease Thromboembolic diseases

Design outcomes

Primary

MeasureTime frame
Clinical Pregnancy. Timepoint: Ten weeks after starting treatment. Method of measurement: Blood tests and ultrasound.

Secondary

MeasureTime frame
Abortion. Timepoint: 10 weeks after embryo transfer. Method of measurement: Blood tests and ultrasound.;Ectopic Pregnancy. Timepoint: 5 weeks after embryo transfer. Method of measurement: Blood tests and ultrasound.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaedeh Ahmadi Dastjerdi

Tehran University of Medical Sciences

dr.maedeh_ahmadi@yahoo.com+98 21 6693 9320

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 6, 2026